Subtype
Early Stage Breast Carcinoma
CI-CAN-00002563Explore in graph →
57 active trials2 approved drugs
- NCIt
- C94774
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00002563Explore in graph →
Clinical trials
145 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (13)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04290897 | Oxaloacetate for the Improvement of Cognitive Complaints in Stage 0-IIIA Breast Cancer Survivors | completed | Phase 2 | 18 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jul 15, 2025 | clinicaltrials |
| NCT04294225 | Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast Cancer | completed | Phase 2 | 161 | Mayo ClinicOTHER | 1 | Jan 28, 2025 | clinicaltrials |
| NCT02698891 |
| Avoiding Growth Factor During Paclitaxel Treatment in Breast Cancer |
| completed |
| Phase 2 |
| 127 |
| Dana-Farber Cancer InstituteOTHER |
| 1 |
| May 6, 2022 |
| clinicaltrials |
| NCT02441946 | A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer(neoMONARCH) | completed | Phase 2 | 224 | Eli Lilly and CompanyINDUSTRY | 10 | Jun 17, 2020 | clinicaltrials |
| NCT01965522 | Anti-proliferative Effects of Vitamin D and Melatonin in Breast Cancer(MELO-D) | completed | Phase 2 | 100 | Juravinski Cancer CenterOTHER | 1 | Jun 16, 2017 | clinicaltrials |
| NCT00165243 | Tangential Radiation Therapy Without Axillary Dissection in Breast Cancer | completed | Phase 2 | 100 | Dana-Farber Cancer InstituteOTHER | 1 | Jun 7, 2017 | clinicaltrials |
Data updated 22 days agoSource updated Jul 15, 2025source: clinicaltrials